findmyKOL

Edwin Rutsky

Basic profile

University of Alabama at Birmingham

ORCIDNone on fileNPI
RegionBirmingham, AL · SoutheastSpecialtyNephrologyFocusNephrology
Last active 2022findmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2022Online presenceNot yet checkedPaymentsNone reportedNIH funding1993–1993Why? →

Edwin Rutsky is a Nephrology physician affiliated with University of Alabama at Birmingham. OpenAlex indexes 36 publications with 2,446 citations (h-index 19).

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
36publications

Distinct works indexed by OpenAlex.

2,446citations

Total citations across indexed works.

19h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
1NIH grants · 1993–1993

Federally funded research awards.

View funding

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

1717 6th Ave S
Birmingham, AL 352331801

Telephone

800-822-8816

Registry record last updated 25 Oct 2022.

View the NPPES registry record

Medicare prescribing footprint (2023)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Cardiovascular

    53.8%
    Statin22.5%
    Atorvastatin Calcium73%Pravastatin Sodium27%
    Part D<11 patients
    Beta blocker10.9%
    Metoprolol Succinate63%Carvedilol37%
    Part D<11 patients

    + 4 more classes in this area

  • Nervous system

    14.2%
    SSRI9.1%
    Escitalopram Oxalate100%
    Part D<11 patients
    gamma-Aminobutyric Acid A Receptor Positive Modulator5.1%
    Zolpidem Tartrate100%
    Part D<11 patients
  • Genitourinary & hormones

    9.8%
    alpha-Adrenergic Blocker5.8%
    Tamsulosin Hcl100%
    Part D<11 patients
    5-alpha Reductase Inhibitor4%
    Finasteride100%
    Part D<11 patients
Where care is delivered (Part B), 2022100% facility · 0% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

NIH funding

1 NIH research award on record, funded 19931993 per NIH RePORTER. The latest:

Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”